Phreesia, Inc. PHR
Nov 5, 2026, 2:38 PM EST
- YTD
- -24.94%
- 1 year
- -43.98%
- Market cap
- 790.16M
- Revenue (ttm)
- 449.67M
- Profit margin
- -5.35%
- EPS (ttm)
- 0.17
- Shares out
- 59.91M
- P/E ratio
- 74.88
- Forward P/E
- -25.76
- YTD return
- -24.94%
- 1-year return
- -43.98%
- Volume
- 384.66K
- Avg volume
- 721.84K
- Open
- 13.30
- Previous close
- 13.18
- Day's range
- 12.51 – 13.39
- 52-week range
- 7.77 – 23.31
- Beta
- 0.64
- Analysts
- Strong Buy
- Price target
- 32.47 (+155.7%)
2Y -5.90 (-31.72%)
Key statistics
- Enterprise value
- 788.45M
- PEG ratio
- 0.00
- Price / sales
- 2.06
- Price / book
- 3.10
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 45.70%
- Free cash flow
- 36.91M
- Total cash
- 439.85M
- Total debt
- 12.64M
- Return on equity
- -8.76%
- Short % of float
- 5.99%
- 50-day average
- 22.08
- 200-day average
- 25.25
Analyst view
Consensus: strong buy
- Target (low)
- 26.00
- Target (mean)
- 32.47
- Target (high)
- 36.00
- Strong buy6
- Buy12
- Hold0
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate 0.36.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Dec 8, 2025 | Oct 1, 2025 | — | 0.10 | — | — |
| Sep 4, 2025 | Jul 1, 2025 | — | 0.01 | +0.08 | +114.29% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 9, 2025 | Citigroup | main | Buy | Buy |
| Dec 9, 2025 | Needham | reit | Buy | Buy |
| Dec 9, 2025 | Canaccord Genuity | main | Buy | Buy |
| Dec 9, 2025 | JP Morgan | main | Overweight | Overweight |
| Dec 9, 2025 | Barclays | init | — | Overweight |
| Dec 8, 2025 | Needham | reit | Buy | Buy |
About Phreesia, Inc.
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers an appointment scheduling system for online appointments, reminders, and referral tracking and management; registration solutions to automate patient self-registration; revenue cycle solutions that provide insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network solutions to deliver clinically relevant content to patients. It deploys its platform in a range of modalities, including Phreesia Mobile, a patients' mobile device; PhreesiaPads, a self-service intake tablets; Phreesia Dashboard, a web-based dashboard for healthcare services clients; and Arrivals Kiosks, which are on-site kiosks. The company serves a range of healthcare services clients, including single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies, as well as government entities and other organizations. Phreesia, Inc. was incorporated in 2005 and is based in Wilmington, Delaware.
- Sector
- Healthcare
- Industry
- Health Information Services
- Country
- United States
- Website
- phreesia.com
News
Phreesia's Sophia Wagner Named to Becker's 2026 List of Health IT & Revenue Cycle Up-and-Comers 
Phreesia: Q3 Must Prove That Growth Can Drive Higher Profitability 
Head-To-Head Comparison: Phreesia (NYSE:PHR) & National Research (NASDAQ:NRC) 
Barclays Maintains Equal-Weight on Phreesia, Raises Price Target to $11 
Argenx, Caribou Biosciences And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session 
Phreesia's Michael Rasbury Named to Becker's 2026 List of Rising Stars: Healthcare Leaders Under 40 
Phreesia Named to TIME's 2026 List of the World's Top HealthTech Companies 
Phreesia (NYSE:PHR) General Counsel Allison Hoffman Sells 6,662 Shares of Stock 
Phreesia's ProviderConnect Audiences are Now Available in the DeepIntent Audience Marketplace 
Why Phreesia Stock Got Knocked Down Today
Your note
Sign in to keep a note on PHR — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CAHILL EDWARD L | Director | Stock Award(Grant) | Oct 30, 2025 | 63,784 |
| GANDHI BALAJI | Chief Financial Officer | Sale | Oct 16, 2025 | 98,240 |
| GOLDSTEIN LAINIE | Director | Stock Award(Grant) | Oct 30, 2025 | 49,366 |
| HOFFMAN ALLISON C | General Counsel | Sale | Oct 16, 2025 | 135,737 |
| HUI YVONNE | Officer | Sale | Oct 14, 2025 | 30,336 |
| INDIG CHAIM EDWARDS | Chief Executive Officer | Sale | Oct 16, 2025 | 1,507,610 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Group Inc | 9.52% | 5,704,786 | 88.17M | Sep 29, 2025 |
| Blackrock Inc. | 9.50% | 5,692,736 | 87.98M | Sep 29, 2025 |
| FMR, LLC | 6.54% | 3,919,084 | 60.57M | Sep 29, 2025 |
| Greenhouse Funds, LLLP | 6.48% | 3,882,527 | 60.00M | Sep 29, 2025 |
| Capital International Investors | 5.23% | 3,134,872 | 48.45M | Sep 29, 2025 |
| Champlain Investment Partners, LLC | 4.47% | 2,678,825 | 41.40M | Sep 29, 2025 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| SmallCap World Fund Inc | 5.23% | 3,134,872 | 48.45M | Sep 29, 2025 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.93% | 1,753,748 | 27.10M | Sep 29, 2025 |
| iShares Trust-iShares Russell 2000 ETF | 2.38% | 1,427,488 | 22.06M | Sep 29, 2025 |
| Franklin Strategic Series-FRANKLIN SMALL CAP GROWTH FUND | 2.13% | 1,278,706 | 19.76M | Jul 30, 2025 |
| Old Westbury Funds Inc-Old Westbury Small & Mid Cap Strategies Fund | 1.86% | 1,115,063 | 17.23M | Jul 30, 2025 |
| Fidelity Select PORT.s-Select Medical Technology and Devices PORT. | 1.80% | 1,080,000 | 16.69M | Sep 29, 2025 |